Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious: Mounjaro ...

Demand for weight loss drugs may fuel growth for more than one player.

Long-time shareholders are already pretty satisfied with these companies, but there might be even more upside ahead.

In May 2026, Viking Therapeutics presented additional Phase 2 VENTURE-Oral data at the European Congress on Obesity, showing that once-daily oral VK2735 produced statistically significant, ...

The global weight-loss drug market has quickly become one of the hottest battlegrounds in healthcare. The explosive ...

In late April 2026, Viking Therapeutics reported a wider first‑quarter net loss of US$158.33 million as research and development spending accelerated, while confirming that its Phase 3 VANQUISH-1 and ...

Investors in Viking Therapeutics Inc (Symbol: VKTX) saw new options begin trading this week, for the May 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to ...

Most investors currently see the glass on this stock as being half-empty. Analysts, however, still view the glass as at least half-full.

Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics (NASDAQ:VKTX). And retail traders should know. We noticed this today when the positions showed up on publicly ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in General Motors Co (Symbol: GM), where a total of 73,915 contracts have traded so far, ...